The research and development team formed by Taiwan Qinyi University of Science and Technology and Xiu Chuan Hospital has developed the "MR+VR smart medical glasses" for five years. Based on MR hybrid virtual reality glasses, it combines VR virtual reality and datagloves data gloves. Let the remote doctors instruct the disaster site personnel to perform surgery or first aid on the injured. It is understood that the key part of this technology, MR hybrid virtual reality smart medical glasses, was developed by the team two years ago. MR smart glasses can see the bones, blood vessels and nerves through the skin. They can also integrate a series of X-rays, computed tomography scans and medical records before surgery to help reduce surgical errors. Currently, the research team has used this technique to complete 60 spinal operations. Li Peiyuan, head of the R&D team, pointed out that their latest smart medical glasses can not only make surgery more precise, but also can be used in hard-hit areas with insufficient medical resources, whether it is a terrorist attack, a battlefield or an earthquake-stricken area, even if there is no medical treatment on site. Personnel, physicians can also use glasses to implement remote guidance. Wang Minliang, the team's technical research and development assistant and assistant professor of Taiwan Qinyi University of Science and Technology, said that "MR+VR smart medical glasses" is simpler and more convenient than the current remote-operation guidance technology through computer, but it has certain requirements for the local network. “The doctors at the mentoring end use VR glasses, and the on-site rescuers use MR smart medical glasses. In many cases, the rescuers who can arrive at the disaster site for the first time have no medical background, and the doctors at the guiding end can intervene in the field through data gloves to guide the field personnel in real time. Make the right first aid." Wang Minliang told reporters. According to reports, "MR + VR smart medical glasses" has successfully completed two clinical tests, and will gradually enter the application test and mass production stage. The R&D team hopes that this system will become a key life-saving tool for disaster relief in the future. (Xinhua) Dingmin Pharmaceutical supply Selexipag API and Selexipag Intermediates with high purity and best price. The main products CAS No are as follows: 475086-01-2, 475086-75-0, 41270-66-0, 243472-70-0, 42042-71-7. Sample can be sent if you request. Cas 475086-75-0,Selexipag Intermediates,6-Diphenylpyrazine Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com
Welcome to do business with us. Please email to us directly.